Robert E. Dudley, Ph.D., has devoted his career to developing products that revolutionize healthcare for men. As the co-inventor of multiple formulations of testosterone replacement therapies, he is a leading voice in hypogonadism and men’s health.
Driven by a mission to help men overcome the symptoms of hypogonadism, Dr. Dudley established Clarus Therapeutics, Inc. in 2004 and has served as Chief Executive Officer, President and Chairman of the Board of Directors since its founding. Prior to founding Clarus Therapeutics, Dr. Dudley served as the President, Chief Executive Officer and Director of Anagen Therapeutics. He also held senior executive positions at Unimed Pharmaceuticals.
Dr. Dudley has more than 25 years of experience in the testosterone replacement therapy field. Most notably, he led the discovery, development, regulatory approval and launch of the first testosterone gel product, which became the market leader.
Dr. Dudley received his Bachelor of Science in biology from Pepperdine University, Seaver College, his Master of Science in biology from the University of New Mexico, and his Ph.D., with honors, in Pharmacology and Toxicology from the University of Kansas School of Medicine. He is also a board-certified toxicologist.
Steven A. Bourne, CPA, is a finance and accounting professional with a passion for working with innovative, early-stage life science companies. He joined Clarus Therapeutics in February 2004 and currently serves as Chief Financial Officer, Secretary and Treasurer. His career has spanned more than two and a half decades, amassing deep financial leadership expertise for specialty pharmaceutical, biotech and medical device companies. Prior to Clarus Therapeutics, he served as Chief Financial Officer, Secretary and Treasurer at Anagen Therapeutics and Treasurer, Secretary and Controller at Aksys, a public medical device company.
Mr. Bourne holds a Bachelor of Science in accounting from Miami University and is a Certified Public Accountant.
As a veteran marketer in the men’s health field, Frank Jaeger has built his career by fostering productive conversations between physicians and consumers and encouraging men to speak to their doctors about sensitive health issues. He joined Clarus Therapeutics, Inc. in September 2019 as Chief Commercial Officer, bringing over 20 years of sales, marketing and business development experience in the healthcare industry. He has a strong record of accomplishments in men’s health, including launching and managing Abbott’s market-leading treatment for low testosterone.
Before joining Clarus Therapeutics, Mr. Jaeger served as Regional Sales Director of the West Region, Metabolic Division and as Director of Men’s Health Marketing, Metabolic Division at AbbVie.
Mr. Jaeger holds a Bachelor of Arts and Master of Arts in psychology from the University of Illinois, Chicago and a Master of Business Administration from the Lake Forest Graduate School of Management.
With extensive experience in both private urology practice and commercial product development, Jay Newmark was already a leading voice in men’s health when he joined Clarus Therapeutics, Inc. in December 2019 as Chief Medical Officer. Following 16 years as a urologist in private practice, he worked to develop advanced detection technologies for prostate cancer as Senior Director of Medical Affairs at Genomic Health and OPKO Health. He has worked closely with commercial development organizations and academic researchers to design clinical trial protocols and co-author publications on topics in oncology and urology.
Dr. Newmark received his M.D. from the University of Michigan Medical School and completed his residency in urology at the Johns Hopkins Hospital. He also holds a Master of Business Administration from the University of Chicago.
LaTonya Wright is a proven leader whose teams consistently exceed ambitious sales targets. She joined Clarus Therapeutics in October 2019 as Vice President, Sales with more than 20 years of healthcare experience gained through roles at Amgen, Abbott and AbbVie. Under her leadership as Regional Sales Director at AbbVie, her team won national awards for sales and performance. Previously, she launched another TRT treatment with an innovative go-to-market model. At Clarus Therapeutics, Ms. Wright is in charge of building and leading the sales organization by developing sales, market access and operational strategies.
Ms. Wright holds a Bachelor of Arts from Michigan State University. She served in the United States Army, reaching the rank of Staff Sergeant.
James Holloway joined Clarus Therapeutics, Inc. in October 2019 as Vice President, Manufacturing and Supply with extensive experience in pharmaceutical manufacturing operations. His background includes roles of increasing responsibility at DSM Pharmaceuticals, Cardinal Health, Pfizer and Boehringer Ingelheim. Prior to Clarus Therapeutics, he led the research and development project management office of the Infection Prevention franchise of CareFusion (now BD Medical), where he increased revenue and improved on-time delivery. Mr. Holloway has launched more than 55 drugs and biologic products.
Mr. Holloway holds a Bachelor of Science and a Master of Science from Fisk University.